onatasertib   Click here for help

GtoPdb Ligand ID: 8914

Synonyms: CC-223 | CC223 | compound 37 [PMID: 26083478]
Compound class: Synthetic organic
Comment: Onatasertib (CC-223) is an investigational inhibitor of the serine/threonine kinase, mechanistic target of rapamycin (mTOR) in mTORC1/2 complexes [1-2].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 8
Hydrogen bond donors 2
Rotatable bonds 4
Topological polar surface area 100.47
Molecular weight 397.21
XLogP 1.7
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES COC1CCC(CC1)N1C(=O)CNc2c1nc(cn2)c1ccc(nc1)C(O)(C)C
Isomeric SMILES COC1CCC(CC1)N1C(=O)CNc2c1nc(cn2)c1ccc(nc1)C(O)(C)C
InChI InChI=1S/C21H27N5O3/c1-21(2,28)17-9-4-13(10-22-17)16-11-23-19-20(25-16)26(18(27)12-24-19)14-5-7-15(29-3)8-6-14/h4,9-11,14-15,28H,5-8,12H2,1-3H3,(H,23,24)
InChI Key UFKLYTOEMRFKAD-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
CC-223 is being evaluated for its antineoplastic efficacy in a variety of liquid and solid tumours.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT01177397 Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma Phase 1/Phase 2 Interventional Celgene